An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma

Autor: Stavrakaki, Eftychia, van den Bossche, Wouter B.L., Vogelezang, Lisette B., Teodosio, Cristina, Mustafa, Dana M., van Dongen, Jacques J.M., Dirven, Clemens M.F., Balvers, Rutger K., Lamfers, Martine L.

Publikováno v: In Cell Reports Methods 25 March 2024 4(3)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An autologous ex vivomodel for exploring patient-specific responses to viro-immunotherapy in glioblastoma

Autor: Stavrakaki, Eftychia, van den Bossche, Wouter B.L., Vogelezang, Lisette B., Teodosio, Cristina, Mustafa, Dana M., van Dongen, Jacques J.M., Dirven, Clemens M.F., Balvers, Rutger K., Lamfers, Martine L.

Publikováno v: Cell Reports Methods; March 2024, Vol. 4 Issue: 3

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy.

Autor: Belcaid Z; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands.; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Berrevoets C; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Choi J; Department of Neurosurgery, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., van Beelen E; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands., Stavrakaki E; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands., Pierson T; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands., Kloezeman J; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands., Routkevitch D; Department of Neurosurgery, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., van der Kaaij M; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Ploeg A; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathios D; Department of Neurosurgery, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Sleijfer S; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dirven C; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands., Lim M; Department of Neurosurgery, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Lamfers MLM; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2020 Feb 03; Vol. 2 (1), pp. vdaa011. Date of Electronic Publication: 2020 Feb 03 (Print Publication: 2020).